158 related articles for article (PubMed ID: 26476799)
1. Does fertility treatment increase the risk of uterine cancer? A meta-analysis.
Saso S; Louis LS; Doctor F; Hamed AH; Chatterjee J; Yazbek J; Bora S; Abdalla H; Ghaem-Maghami S; Thum MY
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():52-60. PubMed ID: 26476799
[TBL] [Abstract][Full Text] [Related]
2. Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis.
Barcroft JF; Galazis N; Jones BP; Getreu N; Bracewell-Milnes T; Grewal KJ; Sorbi F; Yazbek J; Lathouras K; Smith JR; Hardiman P; Thum MY; Ben-Nagi J; Ghaem-Maghami S; Verbakel J; Saso S
Hum Reprod; 2021 Mar; 36(4):1093-1107. PubMed ID: 33586777
[TBL] [Abstract][Full Text] [Related]
3. In vitro fertilisation for unexplained subfertility.
Pandian Z; Bhattacharya S; Vale L; Templeton A
Cochrane Database Syst Rev; 2005 Apr; (2):CD003357. PubMed ID: 15846658
[TBL] [Abstract][Full Text] [Related]
4. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.
Rizzuto I; Behrens RF; Smith LA
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008215. PubMed ID: 23943232
[TBL] [Abstract][Full Text] [Related]
5. Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort.
Brinton LA; Westhoff CL; Scoccia B; Lamb EJ; Trabert B; Niwa S; Moghissi KS
Hum Reprod; 2013 Oct; 28(10):2813-21. PubMed ID: 23943795
[TBL] [Abstract][Full Text] [Related]
6. Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors.
Del Pup L; Peccatori FA; Levi-Setti PE; Codacci-Pisanelli G; Patrizio P
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):8042-8059. PubMed ID: 30536354
[TBL] [Abstract][Full Text] [Related]
7. Uterine cancer after use of clomiphene citrate to induce ovulation.
Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
[TBL] [Abstract][Full Text] [Related]
8. Fertility drugs, reproductive strategies and ovarian cancer risk.
Tomao F; Lo Russo G; Spinelli GP; Stati V; Prete AA; Prinzi N; Sinjari M; Vici P; Papa A; Chiotti MS; Benedetti Panici P; Tomao S
J Ovarian Res; 2014; 7():51. PubMed ID: 24829615
[TBL] [Abstract][Full Text] [Related]
9. Ovulation induction and risk of endometrial cancer: a pilot study.
Benshushan A; Paltiel O; Brzezinski A; Tanos V; Barchana M; Shoshani O; Gordon L; Tsur L; Schenker JG
Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):53-7. PubMed ID: 11516800
[TBL] [Abstract][Full Text] [Related]
10. A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate.
Ingerslev HJ; Højgaard A; Hindkjaer J; Kesmodel U
Hum Reprod; 2001 Apr; 16(4):696-702. PubMed ID: 11278221
[TBL] [Abstract][Full Text] [Related]
11. Endometrial injury in women undergoing in vitro fertilisation (IVF).
Lensen SF; Armstrong S; Gibreel A; Nastri CO; Raine-Fenning N; Martins WP
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD009517. PubMed ID: 34110001
[TBL] [Abstract][Full Text] [Related]
12. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
[TBL] [Abstract][Full Text] [Related]
13. In vitro fertilisation for unexplained subfertility.
Pandian Z; Gibreel A; Bhattacharya S
Cochrane Database Syst Rev; 2012 Apr; (4):CD003357. PubMed ID: 22513911
[TBL] [Abstract][Full Text] [Related]
14. Risk of foetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis.
Pundir J; Achilli C; Bhide P; Sabatini L; Legro RS; Rombauts L; Teede H; Coomarasamy A; Zamora J; Thangaratinam S
Hum Reprod Update; 2021 Apr; 27(3):474-485. PubMed ID: 33374012
[TBL] [Abstract][Full Text] [Related]
15. Risk of cancer after use of fertility drugs with in-vitro fertilisation.
Venn A; Watson L; Bruinsma F; Giles G; Healy D
Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672
[TBL] [Abstract][Full Text] [Related]
16. Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination.
Lensen SF; Manders M; Nastri CO; Gibreel A; Martins WP; Templer GE; Farquhar C
Cochrane Database Syst Rev; 2016 Jun; (6):CD011424. PubMed ID: 27296541
[TBL] [Abstract][Full Text] [Related]
17. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
[TBL] [Abstract][Full Text] [Related]
18. Does salpingectomy have a deleterious impact on ovarian response in in vitro fertilization cycles?
Yoon SH; Lee JY; Kim SN; Chung HW; Park SY; Lee C
Fertil Steril; 2016 Oct; 106(5):1083-1092.e5. PubMed ID: 27336211
[TBL] [Abstract][Full Text] [Related]
19. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.
Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788
[TBL] [Abstract][Full Text] [Related]
20. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.
Youssef MA; van Wely M; Mochtar M; Fouda UM; Eldaly A; El Abidin EZ; Elhalwagy A; Mageed Abdallah AA; Zaki SS; Abdel Ghafar MS; Mohesen MN; van der Veen F
Fertil Steril; 2018 Feb; 109(2):289-301. PubMed ID: 29317127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
